EP2826784
Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.3.2008EP published:
26.6.2019EP application number:
14179358.8
EPO information:
European Patent Register
Max expiry date:
25.3.2028
Title:
Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
Timeline
Today
26.3.2008EP application
26.6.2019EP Publication
Owner
Name:
Gilead Pharmasset LLCAddress:
c/o Gilead Sciences, Inc. 333 Lakeside Drive, 94404, Foster City, CA, US
Inventor
Name:
Du, JinfaAddress:
New HopePA, US
Name:
Wang, PeiyuanAddress:
Glen RockNJ, US
Name:
Nagarathnam, DhanapalanAddress:
BethanyCT, US
Name:
Sofia, Michael JosephAddress:
DoylestownPA, US
Priority
Number:
909315 PDate:
30.3.2007Country:
US
Number:
982309 PDate:
24.10.2007Country:
US
Number:
53015Date:
21.3.2008Country:
US
Classification
Categories:
C07H 19/20, A61K 31/7072, A61P 31/00